Paul Joseph Hampel

36PUBLICATIONS
122CO-AUTHORS
Haematological tumoursHaematologyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

|Jun 04, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

|Apr 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Clive S Zent, Enrico Tiacci, Robert J Kreitman

|Jan 07, 2026
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience.

Domitilla Baccon, Suheil Albert Atallah-Yunes, Paul J Hampel

|Nov 06, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL).

Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh

|Jul 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis.

Samuel Kosydar, William J Archibald, Paul J Hampel

Pageof 6

Frequent Collaborators

28 joint publications

Sameer A Parikh

16 joint publications

Kari G Rabe

13 joint publications

Eli Muchtar

13 joint publications

Yucai Wang